Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 30;10(1):45.
doi: 10.1038/s41421-024-00662-3.

Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue

Jiaying Wu #  1 , Tuo Li #  2 , Meng Guo #  3 , Junsong Ji #  4 , Xiaoxi Meng #  5 , Tianlong Fu #  1 , Tengfei Nie #  1 , Tongkun Wei #  1 , Ying Zhou  1 , Weihua Dong  6 , Ming Zhang  7 , Yongquan Shi  8 , Xin Cheng  9 , Hao Yin  10   11 ; Clinical Group
Collaborators, Affiliations

Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue

Jiaying Wu et al. Cell Discov. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Preclinical studies and clinical outcomes of autologous E-islet transplantation in a T2D patient.
a Brief scheme of major procedures involved in the generation and quality control of E-islets and the safety/effectiveness evaluations of E-islet transplantation. b–d E-islets reverse hyperglycemia in STZ-induced diabetic immunocompromised mice. Schematic illustration of kidney capsule transplantation of E-islets (b). Fasting blood glucose dynamics (blue line: sham group; red line: E-islet-transplanted group, c). Secretion of human C-peptide after fasting and 30 min following an i.p. glucose bolus on days 90 and 180 post transplantation (d). e–g Immunogenicity of E-islets in humanized mice. Schematic illustration of the syngeneic and allogeneic kidney capsule transplantation of patient-specific E-islets into the NCG-hIL15 diabetic mice humanized with the patient’s and a volunteer’s PBMCs (e). Fasting blood glucose dynamics (blue line represents the control group with the patient E-islets transplanted into three diabetic mice humanized with the volunteer’s PBMCs; red line represents the group with the patient E-islets transplanted into three diabetic mice humanized with the patient’s PBMCs, f). Secretion of human C-peptide after fasting and 30 min following an i.p. glucose bolus on days 7 and 14 post E-islet transplantation (U.D. undetectable, g). h Clinical measurements of TITR, TIR and HbA1c, and the insulin dosage during 116 weeks. i Continuous interstitial glucose fluctuations derived from the CGM measurements at weeks 52 and 105 compared with pre-surgery levels. j–l Serum levels of fasting and meal-stimulated circulating glucose (j), C-peptide (k) and insulin (l) from MMTT assays.
See this image and copyright information in PMC

Comment in

References

    1. Talchai, C. et al. Cell150, 1223–1234 (2012). - PMC - PubMed
    1. Chatterjee, S. et al. Lancet389, 2239–2251 (2017). - PubMed
    1. Shapiro, A. M. et al. N. Engl. J. Med.355, 1318–1330 (2006). - PubMed
    1. Marfil-Garza, B. A. et al. Lancet Diabetes Endocrinol.10, 519–532 (2022). - PubMed
    1. Lablanche, S. et al. Lancet Diabetes Endocrinol.6, 527–537 (2018).